Cherry Creek Investment Advisors Inc. bought a new stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund bought 17,853 shares of the company’s stock, valued at approximately $176,000. Other large investors have also recently made changes to their positions in […]
Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) had its target price upped by Needham & Company LLC from $15.00 to $17.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock. Several other brokerages have also recently issued reports on RXRX. TD Cowen initiated coverage on Recursion Pharmaceuticals […]
Recursion Pharmaceuticals (NASDAQ:RXRX) Sees Unusually-High Trading Volume themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) was up 8% on Monday . The stock traded as high as $10.55 and last traded at $10.40. Approximately 868,527 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 7,476,085 shares. The stock had previously closed at $9.63. Analyst Upgrades […]
Yong Rong HK Asset Management Ltd acquired a new position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The firm acquired 1,174,200 shares of the company’s stock, valued at approximately $8,772,000. Recursion Pharmaceuticals accounts for 3.8% of Yong Rong HK Asset […]